|
PDMR
|
GSK Share Option Plan
|
|
Mr P C Thomson
|
Exercise of option over 7,800 Ordinary shares, granted on 28
October 2003 under the GlaxoSmithKline Share Option Plan at a price of £12.68 per share, and sale of 7,800 Ordinary shares at a price of £16.81 per share.
Exercise of option over 4,820 Ordinary shares, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and sale of 4,820 Ordinary shares at a price of £16.815 per share.
Exercise of option over 6,910 Ordinary shares, granted on 21 February 2006 under the GlaxoSmithKline Share Option Plan at a price of £14.68 per share, and sale of 6,910 Ordinary shares at a price of £16.815 per share.
Exercise of option over 6,910 Ordinary shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan at a price of £14.88 per share, and sale of 6,910 Ordinary shares at a price of £16.81387 per share.
Exercise of option over 6,910 Ordinary shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan at a price of £11.47 per share, and sale of 6,910 Ordinary shares at a price of £16.810623 per share.
Exercise of option over 6,910 Ordinary shares, granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan at a price of £11.77 per share, and sale of 6,910 Ordinary shares at a price of £16.81 per share.
Exercise of option over 6,910 Ordinary shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan at a price of £12.035 per share, and sale of 6,910 Ordinary shares at a price of £16.81 per share.
|
|
Connected Person
|
GSK Share Option Plan
|
|
Mrs K Thomson
|
Exercise of option over 6,000 Ordinary shares, granted on 28 October 2003 under the GlaxoSmithKline Share Option Plan at a price of £12.68 per share, and sale of 6,000 Ordinary shares at a price of £16.775 per share.
Exercise of option over 1,570 Ordinary shares, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and sale of 1,570 Ordinary shares at a price of £16.775 per share.
Exercise of option over 974 Ordinary shares, granted on 21 February 2006 under the GlaxoSmithKline Share Option Plan at a price of £14.68 per share, and sale of 974 Ordinary shares at a price of £16.775 per share.
Exercise of option over 1,005 Ordinary shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan at a price of £14.88 per share, and sale of 1,005 Ordinary shares at a price of £16.775 per share.
Exercise of option over 1,005 Ordinary shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan at a price of £11.47 per share, and sale of 1,005 Ordinary shares at a price of £16.775 per share.
Exercise of option over 1,005 Ordinary shares, granted on 17 February 2009 under the GlaxoSmithKline Share Option Plan at a price of £11.77 per share, and sale of 1,005 Ordinary shares at a price of £16.775 per share.
Exercise of option over 551 Ordinary shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan at a price of £12.035 per share, and sale of 551 Ordinary shares at a price of £16.775 per share.
Exercise of option over 867 Ordinary shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan at a price of £12.035 per share, and sale of 867 Ordinary shares at a price of £16.775 per share.
|